Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. Go to Publication You Might Also Like From pulmonary susceptible tuberculosis to extensively drug resistant tuberculosis: An interesting case report of a young Indian girl September 3, 2020 The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. March 15, 2017 A Shorter Regimen for Rifampin-Resistant Tuberculosis. January 9, 2020 The association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. March 3, 2013 A 24-year-old man with giddiness, hemoptysis, and skin lesions. November 13, 2008
From pulmonary susceptible tuberculosis to extensively drug resistant tuberculosis: An interesting case report of a young Indian girl September 3, 2020
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. March 15, 2017
The association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. March 3, 2013